Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 4
1987 1
1989 3
1991 5
1992 1
1993 2
1995 4
1996 2
1997 2
1999 4
2000 3
2001 2
2002 6
2003 4
2004 5
2005 4
2006 2
2007 3
2008 4
2009 3
2010 8
2011 13
2012 3
2013 4
2014 2
2015 2
2016 2
2017 2
2018 8
2019 11
2020 5
2021 6
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
[Chimeric antigen receptor T-cell therapy].
Müller K, Ifversen M, Kielsen K, Petersen SL, Met Ö, Svane IM. Müller K, et al. Among authors: petersen sl. Ugeskr Laeger. 2019 Oct 14;181(20A):V05190309. Ugeskr Laeger. 2019. PMID: 31610841 Free article. Review. Danish.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Polverelli N, Bonneville EF, de Wreede LC, Koster L, Kröger NM, Schroeder T, Peffault de Latour R, Passweg J, Sockel K, Broers AEC, Clark A, Dreger P, Blaise D, Yakoub-Agha I, Petersen SL, Finke J, Chevallier P, Helbig G, Rabitsch W, Sammassimo S, Arcaini L, Russo D, Drozd-Sokolowska J, Raj K, Robin M, Battipaglia G, Czerw T, Hernández-Boluda JC, McLornan DP. Polverelli N, et al. Among authors: petersen sl. Am J Hematol. 2024 May;99(5):993-996. doi: 10.1002/ajh.27262. Epub 2024 Feb 22. Am J Hematol. 2024. PMID: 38385579
Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Wegener A, Andersen NS, Friis LS, Petersen SL, Schjødt I, Kornblit B, Sengeløv H, Gjærde LK. Wegener A, et al. Among authors: petersen sl. Transplant Cell Ther. 2023 Sep;29(9):575.e1-575.e6. doi: 10.1016/j.jtct.2023.05.022. Epub 2023 Jun 9. Transplant Cell Ther. 2023. PMID: 37301257 Free article. Clinical Trial.
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation.
Minculescu L, Reekie J, Petersen SL, Kornblit BT, Schjoedt I, Andersen NS, Andersen LP, Fischer-Nielsen A, Haastrup EK, Friis LS, Sengelov H. Minculescu L, et al. Among authors: petersen sl. Acta Haematol. 2024;147(3):325-332. doi: 10.1159/000534315. Epub 2023 Oct 12. Acta Haematol. 2024. PMID: 37827141
127 results